Why the top of the head is affected by hairloss more than other areas, and treatments such as surgery, medications like minoxidil, finasteride, and RU58841 to treat it.
The user healthydudenextdoor starting a new topical anti-androgen hairloss treatment, Pyrilutamide, and discussing their current regimen of finasteride and minoxidil.
The user has been using finasteride and minoxidil for hairloss but experienced worsening temple recession. They suspect they might be more sensitive to testosterone and are considering trying RU58841 or CB 03 01 as additional treatments.
First patient dosed with Pyrilutamide (Kintor) Phase III for hairloss treatment. Pyrilutamide differs from approved treatments as it competes with DHT to bind hair follicles, potentially reducing side effects.
People are discussing Breezula, a hairloss treatment, with mixed opinions on its value for the cost. Some are interested in it, while others think it's not worth the money.
The conversation is about the mental toll of hairloss and seeking alternatives to finasteride. Suggestions include using minoxidil, considering pumpkin seed oil, and possibly seeking counseling for body dysmorphic disorder.
The conversation discusses the progress of Clascoterone (Breezula) for hairloss treatment, noting that COVID-19 delayed female trials by three months but Phase III trials for males are proceeding with a Special Protocol Assessment filed with the FDA. Users express hope for Breezula as an alternative to existing treatments like finasteride and minoxidil, despite concerns about its potential high cost.
A user reported a 50% increase in testosterone after 18 months of taking dutasteride for hairloss. The conversation includes skepticism about the reliability of single testosterone tests and questions about estrogen levels.
A user humorously questions if they should shave their head due to hairloss, mentioning Ronald Reagan's impressive hair genetics. Replies include jokes and comments about jealousy and distrust towards older individuals with full heads of hair.
A user shared a 15-year experience using minoxidil and finasteride for hairloss, stating that despite never missing a dose, their hairline continued to recede slowly. Other users suggested that the hairloss might be exacerbated by the use of steroids and recommended considering other treatments like dutasteride and RU58841.
A user on dutasteride and oral minoxidil for two years has experienced worsening hairloss and an itchy scalp. Suggestions include increasing medication doses, trying other treatments like RU58841, getting a scalp biopsy, and addressing potential inflammation through diet and topical treatments.
A 40-year-old man shared a 9-month update on his hairloss treatment, which includes 1.25mg finasteride, 8% minoxidil, RU58841, dermarolling, ketoconazole shampoo, and vitamins, with no significant side effects. He has seen improvement in his hair growth and has stopped wearing hats as a result.
A user experienced severe chest pains and shortness of breath after using RU58841 for hairloss and was advised by a doctor that blocking androgens can weaken the heart. They decided to continue with finasteride, minoxidil, and a hair transplant instead.
A 22-year-old man has been using topical melatonin for a year to slow hairloss and it appears to be effective. He's seeking alternatives to finasteride due to potential side effects, and is interested in understanding how melatonin works to prevent hair shedding.
The post and conversation are about the effectiveness of finasteride and dutasteride for hairloss. The conclusion is that the user had better results with finasteride and experienced rapid balding after switching to dutasteride.
RU58841 combined with finasteride or dutasteride is more effective than RU58841 alone for hairloss. Users suggest combining these with minoxidil and microneedling for better results.
HMI-115, a newly discovered hairloss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.
A user's 3-month experience with pyrilutamide to reduce hair shedding, and how it may not be strong enough to stop the thinning of their hairline. Other users mentioned the effectiveness of minoxidil and finasteride for treating hairloss.
Kintor's GT20029, a treatment for hairloss, has completed Phase 1 successfully, showing promise as an androgen receptor degrader that could potentially regrow hair. It is considered more effective than Pyrilutamide, with infrequent dosing and minimal systemic absorption.
The effectiveness of pyrilutamide, a hairloss treatment, with research results being postponed until September. Various people shared their experiences with topical finasteride, minoxidil and RU58841, as well as other treatments such as dandruff shampoo, group buys and grey markets.
The conversation is about a group of people trying KX-826 for hairloss, with no serious side effects reported after 25 days of use. Some participants are experiencing less scalp itch and shedding, but it's too early for definitive results.
A user with low testosterone and mild gyno is considering finasteride for hairloss. Others suggest consulting an endocrinologist first and share experiences of finasteride not worsening gyno.
The conversation discusses the tension theory as a cause of male pattern baldness (MPB), suggesting that scalp tension and reduced subcutaneous fat layer contribute to hairloss. Treatments mentioned include Minoxidil, finasteride, microneedling, scalp massages, and Botox.
The conversation discusses the potential benefits and risks of using Methionine and Glycine for hairloss, with concerns about cancer risk if not balanced properly. The user seeks opinions on these amino acids for hair health and overall benefits.
Switching from finasteride to dutasteride may be more effective for hair regrowth due to dutasteride's stronger enzyme inhibition, but combining both drugs could enhance results. Some users report better outcomes with dutasteride, while others recommend a gradual transition to prevent potential hairloss.
OP is considering adding dutasteride to their regimen of finasteride and minoxidil to address hairloss plateauing. Users suggest oral minoxidil, microneedling, and possibly a hair transplant, with mixed opinions on dutasteride's effectiveness for temple regrowth.
A user has been on dutasteride for nearly 2 years with no improvement in hairloss, expressing frustration. Other users suggest checking for other health conditions, getting bloodwork, and considering stopping TRT or trying finasteride.
A user experienced androgenic alopecia starting at the vertex without frontal hairline recession and is seeking information on this pattern. Another user noted that vertex or diffuse hairloss is common among men.
The conversation discusses HMI 115, a new hairloss treatment with promising results, showing a significant increase in hair density after two months. Some users are skeptical, while others are hopeful for its release and potential affordability.
A user is pleased with their hair regrowth after 3 months using Minoxidil 5%. They plan to start Finasteride upon returning home, and others discuss the importance of consistency and patience with hairloss treatments.